Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance

American Journal of Infection Control

Volumn 42, Issue 12, 2014, Pages 1270-1273

  Kim, Nak Hyun ^a   Han, Woong Dae ^a   Song, Kyoung Ho ^a   Seo, Hye Kyung ^a   Shin, Myoung Jin ^a   Kim, Taek Soo ^b   Park, Kyoung Un ^b   Ahn, Soyeon ^a   Yoo, Jung Sik ^c   Kim, Eu Suk ^a   Kim, Hong Bin ^a  

^a Seoul National University Bundang Hospital   (South Korea)

^b Seoul National University College of Medicine   (South Korea)

^c Korea Centers for Disease Control and Prevention   (South Korea)

Author keywords

Carbapenem resistance; Contact precaution; Enterobacteriaceae

Indexed keywords

1,1 DICHLORO 2,2 BIS(4 CHLOROPHENYL)ETHANE; BETA LACTAMASE; CARBAPENEMASE; IMIPENEM; MEROPENEM; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; CARBAPENEM DERIVATIVE; THIENAMYCIN DERIVATIVE;

ARTICLE; BACTERIUM ISOLATE; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; ESCHERICHIA COLI; HAND WASHING; INFECTION CONTROL; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHENOTYPE; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; PULSED FIELD GEL ELECTROPHORESIS; ANTIBIOTIC RESISTANCE; CROSS INFECTION; DRUG EFFECTS; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; GENETICS; HAZARDOUS WASTE; HUMAN; INCIDENCE; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTIONS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PREVALENCE; PROCEDURES; RETROSPECTIVE STUDY; SOUTH KOREA; TEACHING HOSPITAL;

ANTI-BACTERIAL AGENTS; BACTERIAL PROTEINS; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CARBAPENEMS; CONTAINMENT OF BIOHAZARDS; CROSS INFECTION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE INFECTIONS; HOSPITALS, TEACHING; HUMANS; IMIPENEM; INCIDENCE; INFECTION CONTROL; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; PHENOTYPE; PREVALENCE; PROSPECTIVE STUDIES; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; THIENAMYCINS;

EID: 84961288804     PISSN: 01966553     EISSN: 15273296     Source Type: Journal    
DOI: 10.1016/j.ajic.2014.09.004     Document Type: Article

References (21)

1. Centers for Disease Control and Prevention (CDC). Vital signs: carbapenemresistant Enterobacteriaceae. MMWR Morb Mortal Wkly Rep 2013; 62: 165-70.
2. Yoo JS, Kim HM, Yoo JI, Yang JW, Kim HS, Chung GT, et al. Detection of clonal KPC-2-producing Klebsiella pneumoniae ST258 in Korea during nationwide surveillance in 2011. J Med Microbiol 2013; 62: 1338-42.
3. Kim SY, Shin J, Shin SY, Ko KS. Characteristics of carbapenem-resistant Enterobacteriaceae isolates from Korea. Diagn Microbiol Infect Dis 2013; 76: 486-90.
4. Park YJ, Yu JK, Park KG, Park YG, Lee S, Kim SY, et al. Prevalence and contributing factors of nonsusceptibility to imipenem or meropenem in extendedspectrum beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli. Diagn Microbiol Infect Dis 2011; 71: 87-9.
5. Korea Centers for Disease Control and Prevention. Guidelines for control of patients with carbapenemase producing carbapenem-resistant Enterobacteriaceae. 2012. Available from: http://www.cdc.go.kr/CDC/notice/CdcKrTogether0302.jsp?menuIds=HOME001-MNU1154-MNU0004-MNU0088&cid=9948. Accessed December 1, 2012.
6. Public Health Agency of Canada. Guidance: infection prevention and control measures for healthcare workers in all healthcare settings. Carbapenemresistant gram-negative bacilli. 2010. Available from: http://www.phac-aspc.gc.ca/nois-sinp/guide/ipcm-mpci/ipcm-mpci-eng.php. Accessed July 2, 2013.
7. Centers for Disease Control and Prevention (CDC). Guidance for control of infections with carbapenem-resistant or carbapenemase-producing Enterobacteriaceae in acute care facilities. MMWR Morb Mortality Wkly Rep 2009; 58: 256-60.
8. European Centre for Disease Prevention and Control. Risk assessment on the spread of carbapenemase-producing Enterobacteriaceae (CPE) through patient transfer between healthcare facilities, with special emphasis on cross-border transfer. Stockholm, Sweden: European Centre for Disease Prevention and Control; 2011.
9. Public Health England. Acute trust toolkit for the early detection, management and control of carbapenemase-producing Enterobacteriaceae. London [UK]: Public Health England; 2013.
10. Carmeli Y, Akova M, Cornaglia G, Daikos GL, Garau J, Harbarth S, et al. Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. Clin Microbiol Infect 2010; 16: 102-11.
11. Lowe C, Katz K, McGeer A, Muller MP, Toronto ESBL Working Group. Disparity in infection control practices for multidrug-resistant Enterobacteriaceae. Am J Infect Control 2012; 40: 836-9.
12. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement. Wayne [PA]: Clinical and Laboratory Standards Institute; 2012.
13. World Health Organization. WHO guidelines on hand hygiene in health care: first global patient safety challenge: clean care is safer care. Geneva, Switzerland: World Health Organization, Patient Safety; 2009.
14. Song W, Jeong SH, Kim JS, Kim HS, Shin DH, Roh KH, et al. Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC beta-lactamases and extended-spectrum beta-lactamases in clinical isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis. Diagn Microbiol Infect Dis 2007; 57: 315-8.
15. Franklin C, Liolios L, Peleg AY. Phenotypic detection of carbapenem-susceptible metallo-beta-lactamase-producing gram-negative bacilli in the clinical laboratory. J Clin Microbiol 2006; 44: 3139-44.
16. Endimiani A, Hujer AM, Perez F, Bethel CR, Hujer KM, Kroeger J, et al. Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA. J Antimicrob Chemother 2009; 63: 427-37.
17. Song W, Lee H, Lee K, Jeong SH, Bae IK, Kim JS, et al. CTX-M-14 and CTXM-15 enzymes are the dominant type of extended-spectrum beta-lactamase in clinical isolates of Escherichia coli from Korea. J Med Microbiol 2009; 58: 261-6.
18. Lee K, Lee M, Shin JH, Lee MH, Kang SH, Park AJ, et al. Prevalence of plasmidmediated AmpC beta-lactamases in Escherichia coli and Klebsiella pneumoniae in Korea. Microb Drug Resist 2006; 12: 44-9.
19. Song W, Kim JS, Kim HS, Yong D, Jeong SH, Park MJ, et al. Increasing trend in the prevalence of plasmid-mediated AmpC beta-lactamases in Enterobacteriaceae lacking chromosomal ampC gene at a Korean university hospital from 2002 to 2004. Diagn Microbiol Infect Dis 2006; 55: 219-24.
20. Nordmann P, Gniadkowski M, Giske CG, Poirel L, Woodford N, Miriagou V, et al. Identification and screening of carbapenemase-producing Enterobacteriaceae. Clin Microbiol Infect 2012; 18: 432-8.
21. Lee K, Yong D, Choi YS, Yum JH, Kim JM, Woodford N, et al. Reduced imipenem susceptibility in Klebsiella pneumoniae clinical isolates with plasmid-mediated CMY-2 and DHA-1 beta-lactamases co-mediated by porin loss. Int J Antimicrob Agents 2007; 29: 201-6.